Back to Search
DR. ERIK PETER HENNINGER DO
DO
Pediatrics Physician
NPI: 1164684809Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
DO.1206(AL)
Research & Publications (8)
Lack of effect of TNFalpha blockade therapy on circulating adiponectin levels in patients with autoimmune disease: results from two independent prospective studies.
PMID 19640853·Ann Rheum Dis·2010
2-rct
Evaluation of efalizumab using safe psoriasis control.
PMID 16984639·BMC Dermatol·2006
4-observational
The incidence of arthropathy adverse events in efalizumab-treated patients is low and similar to placebo and does not increase with long-term treatment: pooled analysis of data from Phase III clinical trials of efalizumab.
PMID 17021768·Arch Dermatol Res·2006
3-trial
Safe psoriasis control: a new outcome measure for the composite assessment of the efficacy and safety of psoriasis treatment.
PMID 16699900·J Cutan Med Surg·2005
4-observational
Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139].
PMID 16359548·BMC Dermatol·2005
3-trial
Physiological and psychological effects of delivering medical news using a simulated physician-patient scenario.
PMID 14593853·J Behav Med·2003
3-trial
Ingested IFN-alpha: results of a pilot study in relapsing-remitting MS.
PMID 11552015·Neurology·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 4 locations total
- Address
- 610 Airport Road, Suite 201
Huntsville, AL 35801 - Phone
- (256) 429-4500
Quick Facts
- NPI
- 1164684809
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 4
- Publications
- 8
Are you this provider?
Claim Your Profile